Trending Now
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
AI
Artificial intelligence is transforming the global workforce, but its impact looks different across economies.
Christine Qiang, Global Director in the World Bank’s Digital Vice Presidency, tells GZERO Media’s Tony Maciulis that while “every single job will be reshaped,” developing countries are seeing faster growth in demand for AI skills than high-income nations.
Connectivity remains a critical foundation. “So many people still don't have energy, and many have digital access, but they are not using it,” Qiang notes, stressing the importance of affordable, reliable infrastructure.
She highlights data as “the new electricity” for developing economies to leapfrog into the AI era, provided global governance keeps large language models open and inclusive.
This conversation is presented by GZERO in partnership with Microsoft. The Global Stage series convenes global leaders for critical discussions on the geopolitical and technological trends shaping our world.
Almost 4 billion people lack the infrastructure to participate in the AI revolution. Can business and policy leaders ensure technology narrows, not widens, the global gap?
Vice chair and President of Microsoft, Brad Smith says, "AI will either help close the great divide economically in the world, or it will make it wider." With billions lacking power, internet, and digital literacy, the stakes are high.
Smith argues that only bold partnerships between governments and companies can ensure AI lifts everyone.
Watch more Global Stage coverage from the 80th Session of the United Nations General Assembly here: gzeromedia.com/globalstage
As part of a wide-ranging conversation on the GZERO World podcast, oncologist and Pulitzer prize-winning author Siddhartha Mukherjee walks Ian Bremmer through one of the most groundbreaking uses of AI in medicine today: generative drug discovery. It’s not just about speeding up research—it’s about creating entirely new molecules that no human has ever seen.
Using AI, researchers can now analyze the shape of a dysfunctional protein—like one found in a cancer or autoimmune cell—and generate chemical compounds that could bind to and modify its behavior. “This is true generative chemistry,” Mukherjee says. “Every time we do this in collaboration with a machine, the machine learns it, and it learns it forever.”
The process is like solving a puzzle with a million possible pieces. With each failure, the AI learns more, narrowing down candidates until it finds a match. It’s already produced new antibiotics with never-before-seen structures—and Mukherjee believes this is just the beginning of a medical revolution.
GZERO World with Ian Bremmer, the award-winning weekly global affairs series, airs nationwide on US public television stations (check local listings).
New digital episodes of GZERO World are released every Monday on YouTube. Don't miss an episode: subscribe to GZERO's YouTube channel and turn on notifications (🔔). GZERO World with Ian Bremmer airs on US public television weekly - check local listings.
In 1971, President Nixon declared a “War on Cancer.” Fifty years and billions in research later, the disease still kills 1,700 Americans a day—and survival often depends on income, race, and access to care. But could artificial intelligence finally give humanity the upper hand?
On the latest episode of GZERO World, Ian Bremmer sits down with cancer researcher and bestselling author Siddhartha Mukherjee to explore how AI is changing the trajectory of modern medicine. From early detection and diagnostics to drug discovery and personalized treatment, Mukherjee believes we're entering a new era in the fight against cancer.
“The machine learns it, and it learns it forever,” Mukherjee says, describing how AI can now generate new chemical compounds that have never existed—potentially designing cancer drugs from scratch. “You don’t need to train a new generation of chemists. The machine will now learn it for eternity.”
Mukherjee explains how this generative power can unlock faster, cheaper breakthroughs across all stages of cancer treatment—from identifying new carcinogens like “forever chemicals” to tailoring therapies to a patient’s specific biology. For a disease that touches almost every family, these advances aren’t just technological—they’re deeply personal.
GZERO World with Ian Bremmer, the award-winning weekly global affairs series, airs nationwide on US public television stations (check local listings).
New digital episodes of GZERO World are released every Monday on YouTube.Don't miss an episode: subscribe to GZERO's YouTube channel and turn on notifications (🔔). GZERO World with Ian Bremmer airs on US public television weekly - check local listings.
Listen: Nearly 1 in 2 men and 1 in 3 women in the US will be diagnosed with cancer, and 1,700 people die from it every day. Disparities persist—Black women are 40% more likely to die of breast cancer than white women—and treatment costs remain crushing for many.
On the latest episode of the GZERO World podcast, Ian Bremmer talks with world-renowned cancer researcher and Pulitzer Prize-winning author Siddhartha Mukherjee about the future of medicine—and why artificial intelligence might finally tip the scales in the decades-long war on cancer.
Cancer remains the second leading cause of death in the US, killing nearly 1,700 people every day. But Mukherjee says AI is already reshaping the field, from radiology and diagnostics to identifying new carcinogens and designing entirely new cancer drugs. “Every time we do this in collaboration with a machine,” he explains, “the machine learns it, and it learns it forever.”
In a wide-ranging conversation, Mukherjee breaks down three major areas where AI is advancing medicine: patient care, data mining, and generative drug development. He also weighs in on early cancer detection, how inflammation may hold the key to understanding new carcinogens, and why this moment may be the most hopeful in half a century of cancer research.
Subscribe to the GZERO World Podcast on Apple Podcasts, Spotify, Stitcher, or your preferred podcast platform, to receive new episodes as soon as they're published
President Joe Biden signs an executive order about artificial intelligence as Vice President Kamala Harris looks on at the White House on Oct. 30, 2023.
US President Joe Biden on Monday signed an expansive executive order about artificial intelligence, ordering a bevy of government agencies to set new rules and standards for developers with regard to safety, privacy, and fraud. Under the Defense Production Act, the administration will require AI developers to share safety and testing data for the models they’re training — under the guise of protecting national and economic security. The government will also develop guidelines for watermarking AI-generated content and fresh standards to protect against “chemical, biological, radiological, nuclear, and cybersecurity risks.”
The US order comes the same day that G7 countries agreed to a “code of conduct” for AI companies, an 11-point plan called the “Hiroshima AI Process.” It also came mere days before government officials and tech-industry leaders meet in the UK at a forum hosted by British Prime Minister Rishi Sunak. The event will run tomorrow and Thursday, Nov. 1-2, at Bletchley Park. While several world leaders have passed on attending Sunak’s summit, including Biden and Emmanuel Macron, US Vice President Kamala Harris and European Commission President Ursula von der Leyen plan to participate.
When it comes to AI regulation, the UK is trying to differentiate itself from other global powers. Just last week, Sunak said that “the UK’s answer is not to rush to regulate” artificial intelligence while also announcing the formation of a UK AI Safety Institute to study “all the risks, from social harms like bias and misinformation through to the most extreme risks of all.”
The two-day summit will focus on the risks of AI and its use of large language models trained by huge amounts of text and data.
Unlike von der Leyen’s EU, with its strict AI regulation, the UK seems more interested in attracting AI firms than immediately reining them in. In March, Sunak’s government unveiled its plan for a “pro-innovation” approach to AI regulation. In announcing the summit, the government’s Department for Science, Innovation, and Technology boasted the country’s “strong credentials” in AI: employing 50,000 people, bringing £3.7 billion to the domestic economy, and housing key firms like DeepMind (now owned by Google), while also investing £100 million in AI safety research.
Despite the UK’s light-touch approach so far, the Council on Foreign Relations described the summit as an opportunity for the US and UK, in particular, to align on policy priorities and “move beyond the techno-libertarianism that characterized the early days of AI policymaking in both countries.”- UK AI Safety Summit brings government leaders and AI experts together - GZERO Media ›
- AI agents are here, but is society ready for them? - GZERO Media ›
- Yuval Noah Harari: AI is a “social weapon of mass destruction” to humanity - GZERO Media ›
- Should we regulate generative AI with open or closed models? - GZERO Media ›
- Podcast: Talking AI: Sociologist Zeynep Tufekci explains what's missing in the conversation - GZERO Media ›
- OpenAI is risk-testing Voice Engine, but the risks are clear - GZERO Media ›
- One big thing missing from the AI conversation | Zeynep Tufekci - GZERO Media ›
We've been fighting a war on cancer for over half a century—from Nixon’s 1971 National Cancer Act to the promise of cutting-edge AI therapies today. Ian Bremmer reflects on how that war is going.
The numbers are still grim: nearly 1 in 2 men and 1 in 3 women in the US will be diagnosed with cancer, and 1,700 people die from it every day. Disparities persist—Black women are 40% more likely to die of breast cancer than white women—and treatment costs remain crushing for many.
But there’s progress. Survival rates have more than doubled since the 1960s, and new technologies, especially AI, are opening doors researchers couldn’t imagine a decade ago. For Ian, it’s personal. Both of his parents died of cancer. “If you haven’t had it yourself,” he says, “you know someone who has.” But for the first time in decades, there’s real hope that science may be gaining the upper hand.
GZERO World with Ian Bremmer, the award-winning weekly global affairs series, airs nationwide on US public television stations (check local listings).
New digital episodes of GZERO World are released every Monday on YouTube. Don't miss an episode: subscribe to GZERO's YouTube channel and turn on notifications (🔔). GZERO World with Ian Bremmer airs on US public television weekly - check local listings.